No translate

Nguyễn Vĩnh Nam1; Lương Anh Tùng2; Phạm Nguyễn Vinh3; Đỗ Quang Huân4; Phạm Đức Đạt5; Lê Cao Phương Duy6; Phạm Mạnh Hùng7; Hà Mai Hương8; Nguyễn Đỗ Anh9; Nguyễn Hoàng Anh2; Vũ Đình Hòa2

doi:10.58354/jvc.88.2019.1183

Home

NGHIÊN CỨU LÂM SÀNG Issue: Số 88 , 2019 BỆNH MẠCH VÀNH

No translate

Published: October 13, 2026

10.58354/jvc.88.2019.1183

Abstract

No translate

Keywords

No translate

References

1. Tan Q, Jiang X, Huang S, et al. The clinical efficacy and safety evaluation of ticagrelor for acute coronary syndrome in general ACS patients and diabetic patients: A systematic review and meta-analysis. PLoS One 2017;12(5):e0177872.

DOI: doi.org/10.1371/journal.pone.0177872

2. Wallentin L, Becker RC, Budaj A, et al. Ticagrelor versus clopidogrel in patients with acute coronary syndromes. N Engl J Med 2009;361(11):1045-57.

3. Bonaca MP, Bhatt DL, Cohen M, et al. Long-term use of ticagrelor in patients with prior myocardial infarction. N Engl J Med 2015;372(19):1791-800.

DOI: doi.org/10.1056/nejmoa0904327

4. Goto S, Huang CH, Park SJ, et al. Ticagrelor vs. clopidogrel in Japanese, Korean and Taiwanese patients with acute coronary syndrome -- randomized, double-blind, phase III PHILO study. Circ J 2015;79(11):2452-60.

5. Berger PB, Bhatt DL, Fuster V, et al. Bleeding complications with dual antiplatelet therapy among patients with stable vascular disease or risk factors for vascular disease: results from the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance (CHARISMA) trial. Circulation 2010;121(23):2575-83.

DOI: doi.org/10.1056/nejmoa1500857

6. Easton JD, Aunes M, Albers GW, et al. Risk for Major Bleeding in Patients Receiving Ticagrelor Compared With Aspirin After Transient Ischemic Attack or Acute Ischemic Stroke in the SOCRATES Study (Acute Stroke or Transient Ischemic Attack Treated With Aspirin or Ticagrelor and Patient Outcomes). Circulation 2017;136(10):907-16.

7. Hansson EC, Jideus L, Aberg B, et al. Coronary artery bypass grafting-related bleeding complications in patients treated with ticagrelor or clopidogrel: a nationwide study. Eur Heart J 2016;37(2):189-97.

DOI: doi.org/10.1253/circj.cj-15-0112

8. Chen IC, Lee CH, Fang CC, et al. Efficacy and safety of ticagrelor versus clopidogrel in acute coronary syndrome in Taiwan: A multicenter retrospective pilot study. J Chin Med Assoc 2016;79(10):521-30.

9. Bergmeijer TO, Janssen PWA, van Oevelen M, et al. Incidence and Causes for Early Ticagrelor Discontinuation: A "Real-World" Dutch Registry Experience. Cardiology 2017;138(3):164-8.

DOI: doi.org/10.1016/j.jvs.2010.08.067

10.

10. D'Ascenzo F, Bollati M, Clementi F, et al. Incidence and predictors of coronary stent thrombosis: evidence from an international collaborative meta-analysis including 30 studies, 221,066 patients, and 4276 thromboses. Int J Cardiol 2013;167(2):575-84.